semaglutide fda approved for weight loss Drug Wegovy FDA-Approved Lowering Heart Disease Risk Semaglutide Injections for Weight Loss

Who should consider a cash-pay GLP-1 program Cash-pay GLP-1 programs typically suit individuals who: Have a BMI of 27 or higher with a weight-related comorbidity (high blood pressure, sleep apnea, prediabetes), or BMI of 30 or higher Have insurance that excludes weight loss medications, or have no prescription drug coverage Have tried lifestyle interventions without achieving sustained results Want the convenience and privacy of a fully telehealth-based experience Are comfortable with weekly self-injection (or are interested in oral/sublingual alternatives) GLP-1 medications are not appropriate for everyone

Published 2017 Mar 10

Most major pharmacies (CVS, Walgreens, Walmart) will stock oral Wegovy starting January 2026

The Affordable GLP-1 Solution With enough people pooling purchasing power through their workplace, the group creates real leverage directly with manufacturers, the same way a buying cooperative negotiates better prices than any single buyer could on their own